首页> 美国卫生研究院文献>Protein Science : A Publication of the Protein Society >Crystal structures of ASK1-inhibtor complexes provide a platform for structure-based drug design
【2h】

Crystal structures of ASK1-inhibtor complexes provide a platform for structure-based drug design

机译:ASK1-抑制剂复合物的晶体结构为基于结构的药物设计提供了平台

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

ASK1, a member of the MAPK Kinase Kinase family of proteins has been shown to play a key role in cancer, neurodegeneration and cardiovascular diseases and is emerging as a possible drug target. Here we describe a ‘replacement-soaking’ method that has enabled the high-throughput X-ray structure determination of ASK1/ligand complexes. Comparison of the X-ray structures of five ASK1/ligand complexes from 3 different chemotypes illustrates that the ASK1 ATP binding site is able to accommodate a range of chemical diversity and different binding modes. The replacement-soaking system is also able to tolerate some protein flexibility. This crystal system provides a robust platform for ASK1/ligand structure determination and future structure based drug design.
机译:已显示MAPK激酶激酶家族蛋白的一个成员ASK1在癌症,神经退行性疾病和心血管疾病中起关键作用,并且正在成为可能的药物靶标。在这里,我们描述了一种“置换浸泡”方法,该方法可以确定ASK1 /配体配合物的高通量X射线结构。比较来自3种不同化学型的5种ASK1 /配体复合物的X射线结构,表明ASK1 ATP结合位点能够适应​​一定范围的化学多样性和不同的结合方式。替代品浸泡系统还能够耐受某些蛋白质的柔韧性。该晶体系统为ASK1 /配体结构确定和基于未来结构的药物设计提供了一个强大的平台。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号